Related Experiment Videos
State implementation of the AIDS drug assistance programs.
1Medical University of South Carolina, USA.
Health Care Financing Review
|May 27, 1999
Summary
Acquired Immunodeficiency Syndrome (AIDS) drug assistance programs (ADAPs) are crucial for HIV care access. A 1997 survey revealed how 48 states implemented ADAPs, highlighting the need for increased funding to support this vital safety net.
Area of Science:
- Public Health
- Health Policy
- Infectious Diseases
Background:
- Acquired Immunodeficiency Syndrome (AIDS) drug assistance programs (ADAPs) are essential for providing medication access to uninsured individuals.
- These programs form a critical component of the public health safety net for human immunodeficiency virus (HIV) care.
Purpose of the Study:
- To survey the implementation of ADAPs across 48 U.S. states in 1997.
- To identify key aspects of ADAP operations, including beneficiary numbers, eligibility criteria, waiting list administration, and drug coverage.
Main Methods:
- A survey was conducted in 1997 involving 48 states.
- Data collected focused on program beneficiaries, medical and financial eligibility, waiting list management, and drug formularies, including protease inhibitors.
Main Results:
- The survey detailed the varied implementation strategies of ADAPs across participating states.
- Key operational aspects such as beneficiary reach, eligibility requirements, and waiting list dynamics were identified.
- Drug coverage, notably protease inhibitors, was a significant factor in program scope.
Conclusions:
- ADAPs play a vital role in the public sector safety net for HIV/AIDS care.
- Increased funding is necessary to sustain and enhance the capacity of ADAPs to meet patient needs.